-
Roche's Alecensa gets US FDA approval for adjuvant treatment for people with ALK─positive early─stage lung cancer
20 Apr 2024 05:50 GMT
… and Drug Administration (FDA) has approved Alecensa (alectinib) for adjuvant treatment … s Ministry of Health (IMoH) Pharmaceutical Administration, Switzerland’s Swissmedic, … recurrence following surgery, despite adjuvant chemotherapy. Treating lung cancer …
-
Genentech Wins FDA Approval for First Adjuvant Therapy for ALK-Positive, Earl...
20 Apr 2024 01:30 GMT
… and open-label study comparing adjuvant Alecensa with platinum-based … mechanism of action allows the drug to disrupt downstream ALK … intolerant to crizotinib. The drug picked up another approval in … These data will allow the pharma to file for full approval …
-
Neoadjuvant/Adjuvant Pembrolizumab Regimens Lower RCB in ER+ Breast Cancer
19 Apr 2024 22:16 GMT
… Keytruda) plus chemotherapy, followed by adjuvant pembrolizumab combined with endocrine therapy … the therapy management of these drugs, and we must deal … adding the immuno-oncology drugs vs the AEs that … high-risk population?
The drug is not yet approved for …
-
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
19 Apr 2024 18:55 GMT
… for the drug permits its use as an adjuvant, a therapy … that was surgically removed. For adjuvant therapy, a total of … measure disease-free survival.
Adjuvant treatment with Alecensa reduced the … of them are approved as adjuvant therapies. Roche’s Alecensa …
-
Experimental vaccine found effective against both ocular trachoma and urogenital chlamydia in Phase 1 trial: Lancet
19 Apr 2024 18:16 GMT
… by utilizing two different liposomal adjuvants, the CAF01 and CAF09b.
The … findings suggest that CTH522 when adjuvanted with CAF01, induced robust serum … groups who received the vaccine with the CAF09b adjuvant. Further research through …
-
Philippine FDA grants clearance for YS Biopharma’s hepatitis B vaccine trial
19 Apr 2024 15:46 GMT
The Philippine Food and Drug Administration (PFDA) has granted … escalation study will assess the vaccine’s safety, immunogenicity, and … antigens, combined with PIKA adjuvant of the company, to … YS Biopharma’s PIKA adjuvant technology, the vaccine can elicit a …
-
Roche wins FDA OK for targeted drug in early lung cancer
19 Apr 2024 14:40 GMT
… agency cleared use of the drug, Alecensa, after surgical removal … treatment in that so-called adjuvant setting, during which patients … .
Over the last decade, drugs that harness the immune system … known as ROS1-positive. Drugs aimed at another lung cancer …
-
Improvement Seen in Survival With Adjuvant Pembrolizumab in Kidney Cancer
19 Apr 2024 11:34 GMT
THURSDAY, April 18, 2024 (HealthDay News) — For patients with clear-cell renal cell carcinoma, adjuvant pembrolizumab is associated with a significant and clinically meaningful improvement in overall survival, according to a study published in the April 18 …
-
Roche's Genentech touts label expansion for blockbuster lung cancer drug Alecensa
19 Apr 2024 11:07 GMT
… FDA, with the drug now approved as an adjuvant treatment following tumor …
-
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
19 Apr 2024 11:04 GMT
Adjuvant pembrolizumab therapy after surgery for renal-cell carcinoma was approved on the basis of a significant improvement in disease-free survival in the KEYNOTE-564 trial. Whether the results regarding overall survival from the third prespecified …